Table 2 Description of adherence measures
% adherence a | Physician report | Telephone questionnaire | Pharmacy administrative database | |
|---|---|---|---|---|
Physician reportb | 94.7 | — | n=506 0.036 (0.041) | n=673 0.199 (0.028) |
Physician report b | ||||
Tamoxifen | 93.4 | — | n=136 0.076 (0.085) | n=193 0.267 (0.053) |
Inhibitors | 94.7 | — | n=142 0.050 (0.077) | n=201 0.143 (0.053) |
Tamoxifen + inhibitors | 95.7 | — | n=197 −0.018 (0.046) | n=238 0.019 (0.036) |
Others | 94.0 | — | n=31 −0.094 (0.167) | n=41 0.204 (0.095) |
Telephone questionnaireb | 92.0 | n=506 0.036 (0.041) | — | n=494 0.102 (0.040) |
Telephone questionnaire (high) b | ||||
Tamoxifen | 88.8 | n=136 0.076 (0.085) | — | n=132 0.108 (0.070) |
Inhibitors | 92.6 | n=142 0.050 (0.077) | — | n=140 0.150 (0.081) |
Tamoxifen + inhibitors | 93.8 | n=197 −0.018 (0.046) | — | n=192 0.051 (0.067) |
Others | 91.0 | n=31 −0.094 (0.167) | — | n=30 0.019 (0.130) |
Pharmacy administrative databaseb | 74.7 | n=673 0.199 (0.028) | n=494 0.102 (0.040) | — |
Pharmacy administrative database b | ||||
Tamoxifen | 68.6 | n=193 0.267 (0.053) | n=132 0.108 (0.070) | — |
Inhibitors | 75.5 | n=201 0.143 (0.053) | n=140 0.150 (0.081) | — |
Tamoxifen + inhibitors | 78.5 | n=238 0.019 (0.036) | n=192 0.051 (0.067) | — |
Others | 74.0 | n=41 0.204 (0.095) | n=30 0.019 (0.130) | — |
